2025 Research Grants
We are proud to announce that Gabrielle’s Angel Foundation’s Medical Advisory Board recently approved the funding for 8 new grants of $225,000 each, totaling $1.8 million! We are...
Your support of Gabrielle’s Angel Foundation allows us to push the boundaries of what is scientifically possible for those living with blood cancer. Meet the dedicated research scientists whose cutting-edge ideas are giving patients reason to hope and hear all about their latest breakthroughs below!
Scientists and Doctors Reveal How Genes are Mapping Cures for Cancer
A recently published article in Newsweek discusses the groundbreaking advancements in genetic sequencing that are transforming cancer treatment. It highlights how technologies like whole genome...
Dr Ruella on Improving Access to CAR T-Cell Therapy for Minority Populations in Multiple Myeloma
Marco Ruella, MD, Gabrielle’s Angels grantee in 2014 and 2017 (Medical Advisory Board discretionary funding) and 2019 (Medical Research Award), assistant professor, medicine...
Drug in breast cancer trials shows potential for treating blood cancers
Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug...
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia
Gabrielle’s Angel Foundation grantee Grant Challen, PhD (MRA recipient in 2016 and The Mark Foundation for Cancer Research Collaborative Grant Recipient from 2023) from Washington University in...
FDA approves revumenib, a menin inhibitor, for relapsed or refractory acute leukemia with a KMT2A translocation
Big news from Dana-Farber Cancer Institute regarding the FDA approval of revumenib for the treatment of relapsed acute leukemia! Gabrielle’s Angel Foundation funded Scott Armstrong, MD, PhD...
Surprising findings about blood cell mutations bode well for transplant recipients
After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and immune systems from the ground up from a relatively small number of...
Unraveling the Menin Mystery to Halt Cancer Growth
Exciting news out of Dana-Farber on a the development of new menin-targeting agents that showed promise in clinical trials involving adults with acute myeloid leukemia (AML), one of the...
2023 Funding Updates
With your support in 2023, we were able to fund 6 new individual researchers with grants of $225,000 each as well as co-funding with The Mark Foundation for Cancer Research 2 new collaborative...
2023 Medical Research Awards
Gabrielle’s Angel Foundation’s Medical Advisory Board recently selected 6 talented early career scientists to receive Medical Research Awards for a total of $1.35M in grants! Awards are...
Gabrielle’s Angel Foundation welcomes new Medical Advisory Board member Dr. Sarah Tasian
We are delighted to welcome Dr. Sarah Tasian to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research! Sarah K Tasian, MD is a pediatric oncologist and physician-scientist...